Billionaire Ken Griffin Increased His Position in This Dividend King by 547%
Key PointsGriffin first began buying AbbVie stock after its 2013 spinoff from Abbott Labs.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.